Expand SDGR Menu
SDGR MENU

SDGR Latest Press Releases

-- September 1, 2026 --

Schrdinger to Present at Morgan Stanley Global Healthcare Conference Business Wire 8:30 AM

-- August 14, 2026 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:30 AM

-- August 10, 2026 --

AI Found an Influenza Target That Survives Viral Mutation Globe Newswire 9:10 AM

-- August 5, 2026 --

Schrdinger Reports Second Quarter 2026 Financial Results Business Wire 4:05 PM
Schrdinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery Business Wire 8:30 AM

-- July 27, 2026 --

Schrdinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery Business Wire 7:30 AM

-- July 22, 2026 --

Schrdinger to Announce Second Quarter 2026 Financial Results on August 5 Business Wire 8:30 AM

-- July 20, 2026 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:30 AM

-- July 1, 2026 --

As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data PRNewswire 9:01 AM

-- June 18, 2026 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:30 AM

-- June 16, 2026 --

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It PRNewswire 8:45 AM

-- May 22, 2026 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:30 AM

-- May 5, 2026 --

Schrdinger Reports First Quarter 2026 Financial Results Business Wire 4:05 PM

-- May 4, 2026 --

Schrdinger to Participate in Upcoming Investor Conferences Business Wire 8:30 AM

-- April 21, 2026 --

Schrdinger to Announce First Quarter 2026 Financial Results on May 5 Business Wire 8:30 AM

-- April 17, 2026 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:30 AM
Market Data Delayed 15 Minutes